After the virus has cleared-Can preclinical models be employed for Long COVID research?
View abstract on PubMed
Summary
This summary is machine-generated.Animal models are crucial for understanding Long COVID, a persistent condition after SARS-CoV-2 infection. Research highlights their use in studying mechanisms and evaluating treatments for post-COVID conditions.
Area Of Science
- Infectious Diseases
- Immunology
- Pathology
Background
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) causes COVID-19 and can lead to Long COVID (Post-Acute Sequelae of COVID-19 or PASC).
- Long COVID presents with diverse symptoms like fatigue, dyspnea, and cognitive issues, affecting a significant portion of survivors.
- Mechanisms and effective treatments for Long COVID remain largely unknown.
Purpose Of The Study
- To review animal models used to study SARS-CoV-2 infection and its long-term effects.
- To explore how these models can elucidate Long COVID mechanisms and aid in therapeutic development.
Main Methods
- Review of studies on animal models including mice, hamsters, ferrets, and nonhuman primates (NHPs) infected with SARS-CoV-2.
- Analysis of virology, pathology, immune responses, and multiorgan involvement in these models.
- Highlighting studies examining disease characteristics beyond 14 days post-infection.
Main Results
- Animal models offer insights into the multifaceted pathology of acute and persistent COVID-19.
- Specific models demonstrate potential for studying long-term sequelae, including multiorgan dysfunction.
- These preclinical systems can mimic aspects of human Long COVID, facilitating research.
Conclusions
- Animal models are essential for understanding the underlying mechanisms of Long COVID.
- Preclinical models provide a platform for evaluating the efficacy of potential Long COVID therapeutics.
- Establishing validated Long COVID models is critical for advancing treatment strategies.

